doi: 10.3389/fnins.2019.01112 89 NauckMAFriedrichN
GLP-1 medications safe to continue before surgery in patients with diabetes and obesity owenhaskins Jun 5, 2024 3 min read There are only mild differences in gastric emptying among patients taking glucagon-like peptide-1 (GLP-1) receptor agonist medications for type 2 diabetes and weight loss, according to a meta-analysis and review of 15 randomised studies by researchers from Brigham and Womens Hospital
Chief among them is the induction of hypoglycemia, which can destabilize neuronal homeostasis and increase cortical excitabilityan established precursor of cortical spreading depression, particularly in migraine with aura
This work was supported by the Funds of National Natural Science Foundation of China (82060728), Guizhou Provincial Science and Technology Department (MS [2025-380], Thousand Talents Program), Talents of Guizhou Science and Technology Platform [2021]1350-009, Zunyi Science and Technology Bureau (HZ-2023-173, HZ-2023-09, [2024] No
Bariatrics and weight loss surgery is my ultimate specialty
With this knowledge, studies are being conducted to determine the effects of existing GLP-1 drugs for diabetes on the central nervous system